Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034748 · ClinicalTrials.gov registry record · Phase 1
A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01034748 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 6 participants.
The verdict
NCT01034748, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is single dose study of radiolabeled \[14C\]PF-00299804 in healthy male volunteers to study the absorption, distribution, metabolism and elimination of PF-00299804.
Interventions
- DRUG [14C]PF00299804
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01034748
The ClinicalTrials.gov registry entry for NCT01034748 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [14C]PF00299804 is the first listed.
NCT01034748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01034748 about?
NCT01034748 is a clinical study titled "A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers". This is single dose study of radiolabeled \[14C\]PF-00299804 in healthy male volunteers to study the absorption, distribution, metabolism and elimination of PF-00299804.
What is the current status of trial NCT01034748?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2010-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01034748?
The interventions under investigation include: [14C]PF00299804 (DRUG).
Who is sponsoring clinical trial NCT01034748?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.